Micah Ostrowski, Yeonjung Jo, Georges Gebrael, Zeynep Irem Ozay, Varun Nandakumar, Edwin Lin, Nicolas Sayegh, Ayana Srivastava, Vinay Mathew Thomas, Haoran Li, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami. "Survival outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving lutetium Lu 177 vipivotide tetraxetan (Lu) by prior taxane exposure.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.101